Phosphoinositide 3-Kinase Regulates Glycolysis through Mobilization of Aldolase from the Actin Cytoskeleton

Cell

Volumn 164, Issue 3, 2016, Pages 433-446

  Hu, Hai ^a   Juvekar, Ashish ^a   Lyssiotis, Costas A ^b,i   Lien, Evan C ^c   Albeck, John G ^a,j   Oh, Doogie ^d   Varma, Gopal ^e   Hung, Yin Pun ^f   Ullas, Soumya ^c   Lauring, Josh ^g   Seth, Pankaj ^c   Lundquist, Mark R ^b   Tolan, Dean R ^h   Grant, Aaron K ^e   Needleman, Daniel J ^d   Asara, John M ^c   Cantley, Lewis C ^b   Wulf, Gerburg M ^a  

^a HARVARD MEDICAL SCHOOL   (United States)

^b WEILL CORNELL MEDICAL COLLEGE   (United States)

^c BETH ISRAEL DEACONESS MEDICAL CENTER   (United States)

^d HARVARD UNIVERSITY   (United States)

^e Harvard University ^*  (United States)

^f BRIGHAM AND WOMEN S HOSPITAL   (United States)

^g JOHNS HOPKINS UNIVERSITY   (United States)

^h Boston University   (United States)

ⁱ UNIVERSITY OF MICHIGAN MEDICAL SCHOOL   (United States)

^j UNIVERSITY OF CALIFORNIA   (United States)

more..

Author keywords

[No Author keywords available]

Indexed keywords

8 [4 (1 AMINOCYCLOBUTYL)PHENYL] 9 PHENYL 1,2,4 TRIAZOLO[3,4 F][1,6]NAPHTHYRIDIN 3(2H) ONE; ALPELISIB; BUPARLISIB; FRUCTOSE BISPHOSPHATE ALDOLASE; GROWTH FACTOR; INSULIN; PHOSPHATIDYLINOSITOL 3 KINASE; RAC PROTEIN; RAPAMYCIN;

ACTIN FILAMENT; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BREAST CANCER; BREAST EPITHELIUM CELL; CELL ADHESION; CELL CULTURE; CELL FRACTIONATION; CELL METABOLISM; CELL MOTION; CELL PERMEABILIZATION; CELL STIMULATION; CONTROLLED STUDY; ENZYME ACTIVATION; ENZYME ACTIVITY; ENZYME INHIBITION; EPITHELIUM CELL; FEMALE; GENETIC TRANSFECTION; GLUCOSE TRANSPORT; GLYCOLYSIS; IMMUNOFLUORESCENCE; IN VITRO STUDY; MOUSE; NONHUMAN; POSITRON EMISSION TOMOGRAPHY; PRIORITY JOURNAL; REGULATORY MECHANISM; SIGNAL TRANSDUCTION; ANIMAL; ANTAGONISTS AND INHIBITORS; BREAST TUMOR; CYTOSKELETON; CYTOSOL; DISEASE MODEL; HUMAN; METABOLISM; TUMOR CELL LINE;

ANIMALS; BREAST NEOPLASMS; CELL LINE, TUMOR; CYTOSKELETON; CYTOSOL; DISEASE MODELS, ANIMAL; EPITHELIAL CELLS; FRUCTOSE-BISPHOSPHATE ALDOLASE; GLYCOLYSIS; HUMANS; INSULIN; MICE; PHOSPHATIDYLINOSITOL 3-KINASES; SIGNAL TRANSDUCTION;

EID: 84955560430     PISSN: 00928674     EISSN: 10974172     Source Type: Journal    
DOI: 10.1016/j.cell.2015.12.042     Document Type: Article

References (37)

1. K.R. Albe, M.H. Butler, and B.E. Wright Cellular concentrations of enzymes and their substrates J. Theor. Biol. 143 1990 163 195
2. H. Arnold, and D. Pette Binding of aldolase and triosephosphate dehydrogenase to F-actin and modification of catalytic properties of aldolase Eur. J. Biochem. 15 1970 360 366
3. A. Barthel, A.D. Kohn, Y. Luo, and R.A. Roth A constitutively active version of the Ser/Thr kinase Akt induces production of the ob gene product, leptin, in 3T3-L1 adipocytes Endocrinology 138 1997 3559 3562
4. V. Benard, B.P. Bohl, and G.M. Bokoch Characterization of rac and cdc42 activation in chemoattractant-stimulated human neutrophils using a novel assay for active GTPases J. Biol. Chem. 274 1999 13198 13204
5. S.M. Brachmann, C.M. Yballe, M. Innocenti, J.A. Deane, D.A. Fruman, S.M. Thomas, and L.C. Cantley Role of phosphoinositide 3-kinase regulatory isoforms in development and actin rearrangement Mol. Cell. Biol. 25 2005 2593 2606
6. L.C. Cantley The phosphoinositide 3-kinase pathway Science 296 2002 1655 1657
7. L.C. Cantley, K.R. Auger, C. Carpenter, B. Duckworth, A. Graziani, R. Kapeller, and S. Soltoff Oncogenes and signal transduction Cell 64 1991 281 302
8. P. Furet, V. Guagnano, R.A. Fairhurst, P. Imbach-Weese, I. Bruce, M. Knapp, C. Fritsch, F. Blasco, J. Blanz, R. Aichholz, and et al. Discovery of NVP-BYL719 a potent and selective phosphatidylinositol-3 kinase alpha inhibitor selected for clinical evaluation Bioorg. Med. Chem. Lett. 23 2013 3741 3748
9. J.P. Gustin, B. Karakas, M.B. Weiss, A.M. Abukhdeir, J. Lauring, J.P. Garay, D. Cosgrove, A. Tamaki, H. Konishi, Y. Konishi, and et al. Knockin of mutant PIK3CA activates multiple oncogenic pathways Proc. Natl. Acad. Sci. USA 106 2009 2835 2840
10. S. Hanna, and M. El-Sibai Signaling networks of Rho GTPases in cell motility Cell. Signal. 25 2013 1955 1961
11. S.J. Harris, and D.J. Winzor Enzyme kinetic evidence of active-site involvement in the interaction between aldolase and muscle myofibrils Biochim. Biophys. Acta 911 1987 121 126
12. Y.P. Hung, J.G. Albeck, M. Tantama, and G. Yellen Imaging cytosolic NADH-NAD(+) redox state with a genetically encoded fluorescent biosensor Cell Metab. 14 2011 545 554
13. V. Jagannathan, K. Singh, and M. Damodaran Carbohydrate metabolism in citric acid fermentation. 4. Purification and properties of aldolase from Aspergillus niger Biochem. J. 63 1956 94 105
14. H. Jijakli, H.X. Zhang, E. Dura, R. Ramirez, A. Sener, and W.J. Malaisse Effects of cytochalasin B and D upon insulin release and pancreatic islet cell metabolism Int. J. Mol. Med. 9 2002 165 172
15. H.E. Johnson, S.J. King, S.B. Asokan, J.D. Rotty, J.E. Bear, and J.M. Haugh F-actin bundles direct the initiation and orientation of lamellipodia through adhesion-based signaling J. Cell Biol. 208 2015 443 455
16. T. Joneson, M. McDonough, D. Bar-Sagi, and L. Van Aelst RAC regulation of actin polymerization and proliferation by a pathway distinct from Jun kinase Science 274 1996 1374 1376
17. A. Juvekar, L.N. Burga, H. Hu, E.P. Lunsford, Y.H. Ibrahim, J. Balmañà, A. Rajendran, A. Papa, K. Spencer, C.A. Lyssiotis, and et al. Combining a PI3K inhibitor with a PARP inhibitor provides an effective therapy for BRCA1-related breast cancer Cancer Discov. 2 2012 1048 1063
18. J. Lauring, D.P. Cosgrove, S. Fontana, J.P. Gustin, H. Konishi, A.M. Abukhdeir, J.P. Garay, M. Mohseni, G.M. Wang, M.J. Higgins, and et al. Knock in of the AKT1 E17K mutation in human breast epithelial cells does not recapitulate oncogenic PIK3CA mutations Oncogene 29 2010 2337 2345
19. A.M. Lebensohn, and M.W. Kirschner Activation of the WAVE complex by coincident signals controls actin assembly Mol. Cell 36 2009 512 524
20. J.W. Locasale, A.R. Grassian, T. Melman, C.A. Lyssiotis, K.R. Mattaini, A.J. Bass, G. Heffron, C.M. Metallo, T. Muranen, H. Sharfi, and et al. Phosphoglycerate dehydrogenase diverts glycolytic flux and contributes to oncogenesis Nat. Genet. 43 2011 869 874
21. S.M. Maira, S. Pecchi, A. Huang, M. Burger, M. Knapp, D. Sterker, C. Schnell, D. Guthy, T. Nagel, M. Wiesmann, and et al. Identification and characterization of NVP-BKM120, an orally available pan-class I PI3-kinase inhibitor Mol. Cancer Ther. 11 2012 317 328
22. I.A. Mayer, V.G. Abramson, S.J. Isakoff, A. Forero, J.M. Balko, M.G. Kuba, M.E. Sanders, J.T. Yap, A.D. Van den Abbeele, Y. Li, and et al. Stand up to cancer phase Ib study of pan-phosphoinositide-3-kinase inhibitor buparlisib with letrozole in estrogen receptor-positive/human epidermal growth factor receptor 2-negative metastatic breast cancer J. Clin. Oncol. 32 2014 1202 1209
23. H. Miki, S. Suetsugu, and T. Takenawa WAVE, a novel WASP-family protein involved in actin reorganization induced by Rac EMBO J. 17 1998 6932 6941
24. A.J. Morris, R.C. Davenport, and D.R. Tolan A lysine to arginine substitution at position 146 of rabbit aldolase A changes the rate-determining step to Schiff base formation Protein Eng. 9 1996 61 67
25. 13C]pyruvate Sci. Transl. Med. 5 2013 198ra108
26. H. Pelicano, R.H. Xu, M. Du, L. Feng, R. Sasaki, J.S. Carew, Y. Hu, L. Ramdas, L. Hu, M.J. Keating, and et al. Mitochondrial respiration defects in cancer cells cause activation of Akt survival pathway through a redox-mediated mechanism J. Cell Biol. 175 2006 913 923
27. J.C. Rathmell, C.J. Fox, D.R. Plas, P.S. Hammerman, R.M. Cinalli, and C.B. Thompson Akt-directed glucose metabolism can prevent Bax conformation change and promote growth factor-independent survival Mol. Cell. Biol. 23 2003 7315 7328
28. S. Rottenberg, A.O. Nygren, M. Pajic, F.W. van Leeuwen, I. van der Heijden, K. van de Wetering, X. Liu, K.E. de Visser, K.G. Gilhuijs, O. van Tellingen, and et al. Selective induction of chemotherapy resistance of mammary tumors in a conditional mouse model for hereditary breast cancer Proc. Natl. Acad. Sci. USA 104 2007 12117 12122
29. J.D. Rotty, C. Wu, and J.E. Bear New insights into the regulation and cellular functions of the ARP2/3 complex Nat. Rev. Mol. Cell Biol. 14 2013 7 12
30. Y. Samuels, Z. Wang, A. Bardelli, N. Silliman, J. Ptak, S. Szabo, H. Yan, A. Gazdar, S.M. Powell, G.J. Riggins, and et al. High frequency of mutations of the PIK3CA gene in human cancers Science 304 2004 554
31. F. Schapira Aldolase isozymes in cancer Eur. J. Cancer 2 1966 131 134
32. J.A. Sibley Significance of serum aldolase levels Ann. N Y Acad. Sci. 75 1958 339 348
33. G. Varma, X. Wang, E. Vinogradov, R.S. Bhatt, V.P. Sukhatme, P. Seth, R.E. Lenkinski, D.C. Alsop, and A.K. Grant Selective spectroscopic imaging of hyperpolarized pyruvate and its metabolites using a single-echo variable phase advance method in balanced SSFP Magn. Reson. Med. 2015 10.1002/mrm.26004 Published online October 28, 2015
34. J. Wang, A.J. Morris, D.R. Tolan, and L. Pagliaro The molecular nature of the F-actin binding activity of aldolase revealed with site-directed mutants J. Biol. Chem. 271 1996 6861 6865
35. O.C.W. Warburg Gaerungsfermente im Blutserum von Tumor-ratten Biochem. Z. 314 1945 399 408
36. T.H. Witney, M.I. Kettunen, and K.M. Brindle Kinetic modeling of hyperpolarized 13C label exchange between pyruvate and lactate in tumor cells J. Biol. Chem. 286 2011 24572 24580
37. C.Y. Wu, E.S. Carpenter, K.K. Takeuchi, C.J. Halbrook, L.V. Peverley, H. Bien, J.C. Hall, K.E. DelGiorno, D. Pal, Y. Song, and et al. PI3K regulation of RAC1 is required for KRAS-induced pancreatic tumorigenesis in mice Gastroenterology 147 2014 1405 1416